Literature DB >> 26654759

MicroRNA-2861 regulates programmed necrosis in cardiomyocyte by impairing adenine nucleotide translocase 1 expression.

Kun Wang1, Bo Long2, Na Li3, Ling Li3, Cui-Yun Liu4, Yan-Han Dong4, Jin-Ning Gao4, Lu-Yu Zhou4, Chao-Qun Wang4, Pei-Feng Li5.   

Abstract

Necrosis is programmed and is one of the main forms of cell death in the pathological process in cardiac diseases. MicroRNAs (miRNAs) have emerged as key gene regulators in many diseases. However, how miRNAs contribute to programmed necrosis is poorly defined. Here we report that miR-2861 and adenine nucleotide translocase 1 (ANT1) constitute an axis that regulates necrotic cell death in the heart. Our results show that ANT1 inhibits H2O2-induced cardiomyocytes necrosis. ANT1 also antagonizes myocardial necrosis in a mouse ischemia/reperfusion (I/R) model. We further demonstrate that miR-2861 directly binds to the coding sequence of ANT1 and suppresses the expression of ANT1 mRNA and protein. MiR-2861 induces necrotic cell death. In contrast, knockdown of miR-2861 attenuates H2O2-induced necrosis in cardiomyocytes. Also, miR-2861 knockdown protects heart from I/R injury and necrotic cell death in vivo. MiR-2861 regulates necrosis and myocardial infarction through targeting ANT1. Collectively, these data identify miR-2861 and ANT1 as two novel regulators of cardiomyocyte necrosis and myocardial infarction, and suggest potential therapeutic targets in treatment of cardiac diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26654759     DOI: 10.1016/j.freeradbiomed.2015.11.031

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 2.  Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.

Authors:  Yanhan Dong; Cuiyun Liu; Yanfang Zhao; Murugavel Ponnusamy; Peifeng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

Review 3.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

Review 4.  MicroRNA-mediated control of myocardial infarction in diabetes.

Authors:  Daniel Pérez-Cremades; Jingshu Chen; Carmel Assa; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2022-01-17       Impact factor: 8.049

5.  Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions.

Authors:  Chen Zhang; Hui Jiang; Pin Wang; Heng Liu; Xiulian Sun
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 6.  The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.

Authors:  Jinning Gao; Wenhua Xu; Jianxun Wang; Kun Wang; Peifeng Li
Journal:  Int J Mol Sci       Date:  2017-03-10       Impact factor: 5.923

7.  Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Shannon Martello; Michelle A Bylicky; Sunita Chopra; Jared M May; Aman Shankardass; Laurel MacMillan; Landy Sun; Jaleal Sanjak; Claire Vanpouille-Box; Iris Eke; C Norman Coleman
Journal:  J Transl Med       Date:  2021-08-07       Impact factor: 5.531

Review 8.  The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application.

Authors:  Teng Sun; Yan-Han Dong; Wei Du; Chun-Ying Shi; Kun Wang; Muhammad-Akram Tariq; Jian-Xun Wang; Pei-Feng Li
Journal:  Int J Mol Sci       Date:  2017-03-31       Impact factor: 6.208

Review 9.  Functional Role of microRNAs in Regulating Cardiomyocyte Death.

Authors:  Urna Kansakar; Fahimeh Varzideh; Pasquale Mone; Stanislovas S Jankauskas; Gaetano Santulli
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.